Customized liver organoids as an advanced in vitro modeling and drug discovery platform for non-alcoholic fatty liver diseases

Non-alcoholic fatty liver disease (NAFLD) and its progressive form non-alcoholic steatohepatitis (NASH) have presented a major and common health concern worldwide due to their increasing prevalence and progressive development of severe pathological conditions such as cirrhosis and liver cancer. Alth...

Descripción completa

Detalles Bibliográficos
Autores principales: Han, Dong Wook, Xu, KangHe, Jin, Zhe-Long, Xu, Yong-Nan, Li, Ying-Hua, Wang, Lin, Cao, Qilong, Kim, Kee-Pyo, Ryu, DongHee, Hong, Kwonho, Kim, Nam-Hyung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10367556/
https://www.ncbi.nlm.nih.gov/pubmed/37497008
http://dx.doi.org/10.7150/ijbs.85145

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10367556/
https://www.ncbi.nlm.nih.gov/pubmed/37497008
http://dx.doi.org/10.7150/ijbs.85145

Ejemplares similares